Physician profile
Michael P Bernstein
NPI 1356345326
$1,950.49
in general payments reported to CMS, 2019-2025
18 companies · $306 in 2025
The $306 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $444 · 2020: $61.23 · 2021: $26.35 · 2022: $277 · 2023: $472 · 2024: $365 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,142.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,117.50 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $178.85 | 2019-2023 | Eliquis, Camzyos |
| Pfizer INC. | $118.39 | 2021-2024 | |
| Medtronic Vascular, INC. | $105.77 | 2019 | |
| Kiniksa Pharmaceuticals, Ltd. | $82.09 | 2022-2023 | Arcalyst |
| Medtronic, INC. | $78.14 | 2025 | Azure Xt Dr Mri Surescan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.72 | 2019-2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $37.24 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $34.59 | 2019-2020 | |
| Kiniksa Pharmaceuticals International, Plc | $32.28 | 2024 | Arcalyst |
| Inspire Medical Systems, INC. | $24.03 | 2023 | Inspire |
| Abbott Laboratories | $19.46 | 2025 | Mitraclip |
| Boston Scientific Corporation | $19.01 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $13.11 | 2023 | Inpefa |
| Merck Sharp & Dohme LLC | $12.89 | 2023 | Verquvo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $12.45 | 2022 | |
| Gilead Sciences, INC. | $12.15 | 2019 | |
| Amgen INC. | $11.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bernstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.